• Explore /
  • Poster
  • / Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV).

Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV).

Abstract Poster

Authors

null

Antony Mersiades

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia

Antony Mersiades , Annette Tognela , Paul Haber , Martin R. Stockler , Nicholas Lintzeris , Iain McGregor , Ian Olver , David J Allsop , Craig Gedye , Adrienne Kirby , Rachael L Morton , Anh T Tran , Karen P. Briscoe , Peter Fox , Stephen John Clarke , Morteza Aghmesheh , Nicole Wong , Anna Walsh , Carmel Hahn , Peter S. Grimison

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Palliative Care and Symptom Management

Clinical Trial Registration Number

12616001036404

Citation

J Clin Oncol 36, 2018 (suppl; abstr TPS10128)

DOI

10.1200/JCO.2018.36.15_suppl.TPS10128

Abstract #

TPS10128

Poster Bd #

114b

Abstract Disclosures

Similar Posters

First Author: Antony Mersiades

First Author: Lee S. Schwartzberg

First Author: Sneh Bhargave Sr.

First Author: Rudolph M. Navari